Article citationsMore>>

Hale, G., Slavin, S., Goldman, J.M., et al. (2002) Alemtuzumab (Campath-1H) for Treatment of Lymphoid Malignancies in the Age of Non Myeloablative Conditioning. Bone Marrow Transplant, 30, 797-804.
http://dx.doi.org/10.1038/sj.bmt.1703733

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top